Using a combination of bioinformatic and experimental analyses, we have prioritized and analyzed a subset of variants that are most likely to affect the regulation of BRCA1 and BRCA2 and thus have the most potential to contribute to BC risk. Here, BRCA1 is linked to breast cancer.